Leveraging international stakeholders' experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study.

Saved in:
Bibliographic Details
Title: Leveraging international stakeholders' experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study.
Authors: Heck CJ; Department of Epidemiology, Columbia University Mailman School of Public Health, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America. cjh2204@cumc.columbia.edu.; Division of Infectious Diseases, Columbia University Irving Medical Center, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America. cjh2204@cumc.columbia.edu., Kripke K; Avenir Health, Takoma Park, MD, United States of America., Dam A; United States Agency for International Development, Washington, DC, United States of America., Torres-Rueda S; The London School of Hygiene and Tropical Medicine, London, United Kingdom., Bozzani F; The London School of Hygiene and Tropical Medicine, London, United Kingdom., Obermeyer C; The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland., Yohannes K; University of Virginia School of Medicine, Charlottesville, VA, United States of America., Deacon J; The CDC Foundation, Atlanta, GA, United States of America., Meyers K; Division of Infectious Diseases, Columbia University Irving Medical Center, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America.; The Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY, United States of America., Quigee D; Division of Infectious Diseases, Columbia University Irving Medical Center, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America., Wiant S; Division of Infectious Diseases, Columbia University Irving Medical Center, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America., Forsythe S; Avenir Health, Glastonbury, CT, United States of America., Malati C; United States Agency for International Development, Washington, DC, United States of America., Larson M; FHI 360, Durham, NC, United States of America., Sobieszczyk ME; Division of Infectious Diseases, Columbia University Irving Medical Center, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America., Castor D; Department of Epidemiology, Columbia University Mailman School of Public Health, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America. dc2022@cumc.columbia.edu.; Division of Infectious Diseases, Columbia University Irving Medical Center, 622 West 168th Street, 8th Floor, New York, NY, 10032, United States of America. dc2022@cumc.columbia.edu.
Source: Health research policy and systems [Health Res Policy Syst] 2024 Nov 25; Vol. 22 (1), pp. 156. Date of Electronic Publication: 2024 Nov 25.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101170481 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-4505 (Electronic) Linking ISSN: 14784505 NLM ISO Abbreviation: Health Res Policy Syst Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1478-4505
DOI:10.1186/s12961-024-01240-5